feed,title,long_url,short_url
Benzinga,Amkor Technology Reports Financial Results for the Fourth Quarter and Full Year 2020,https://www.benzinga.com/pressreleases/21/02/b19547325/amkor-technology-reports-financial-results-for-the-fourth-quarter-and-full-year-2020,https://j.mp/2MMTizR
Benzinga,Nuance Announces First Quarter 2021 Results,https://www.benzinga.com/pressreleases/21/02/n19547294/nuance-announces-first-quarter-2021-results,https://j.mp/2Z0kRYS
Benzinga,HealthEquity Reports Year-End Sales Metrics,https://www.benzinga.com/pressreleases/21/02/g19547289/healthequity-reports-year-end-sales-metrics,https://j.mp/3tHmFUG
Benzinga,"FutureFuel to Release Year-End 2020 Financial Results on March 16, 2021",https://www.benzinga.com/pressreleases/21/02/g19547287/futurefuel-to-release-year-end-2020-financial-results-on-march-16-2021,https://j.mp/3a2j101
Benzinga,"Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2020 with Webcast and Conference Call Today at 4:30 p.m. ET",https://www.benzinga.com/pressreleases/21/02/b19547288/enanta-pharmaceuticals-reports-financial-results-for-its-fiscal-first-quarter-ended-december-31-20,https://j.mp/3tMSAn5
Benzinga,"Jack Henry & Associates, Inc. Reports Second Quarter Fiscal 2021 Results",https://www.benzinga.com/pressreleases/21/02/n19547259/jack-henry-associates-inc-reports-second-quarter-fiscal-2021-results,https://j.mp/36UqVXb
Benzinga,Luminex Corporation Reports Fourth Quarter and Full-Year 2020 Results,https://www.benzinga.com/pressreleases/21/02/n19547256/luminex-corporation-reports-fourth-quarter-and-full-year-2020-results,https://j.mp/2YX5QXR
Benzinga,Quantum Announces Closing of Public Offering and Full Exercise of Greenshoe Option,https://www.benzinga.com/pressreleases/21/02/n19547255/quantum-announces-closing-of-public-offering-and-full-exercise-of-greenshoe-option,https://j.mp/36Usncg
Benzinga,Nuance Announces Acquisition of Saykara,https://www.benzinga.com/pressreleases/21/02/n19547253/nuance-announces-acquisition-of-saykara,https://j.mp/3p1l4Wy
Benzinga,"CDK Global, Inc. Reports Second Quarter Fiscal 2021 Results",https://www.benzinga.com/pressreleases/21/02/g19547249/cdk-global-inc-reports-second-quarter-fiscal-2021-results,https://j.mp/3tH2BSH
Benzinga,"Opiant Pharmaceuticals Announces First Patient Dosed in Confirmatory Pharmacokinetic Study Assessing OPNT003, Nasal Nalmefene, for the Treatment of Opioid Overdose",https://www.benzinga.com/pressreleases/21/02/g19547246/opiant-pharmaceuticals-announces-first-patient-dosed-in-confirmatory-pharmacokinetic-study-assessi,https://j.mp/3q3n5To
Benzinga,"Kforce Reports Fourth Quarter 2020 Revenue of $354.0 Million; EPS of $0.86 per Share, Up 30.3% Year-Over-Year; Tech Flex Growth Accelerates 5.7% Sequentially on a Billing Day Basis; Board of Directors Approves 15% Increase in Dividend",https://www.benzinga.com/pressreleases/21/02/g19547245/kforce-reports-fourth-quarter-2020-revenue-of-354-0-million-eps-of-0-86-per-share-up-30-3-year-ove,https://j.mp/3p2sXuw
Benzinga,Atea Pharmaceuticals Announces Publication of Preclinical Data Highlighting Potent Activity of AT-527 Against SARS-CoV-2,https://www.benzinga.com/pressreleases/21/02/g19547244/atea-pharmaceuticals-announces-publication-of-preclinical-data-highlighting-potent-activity-of-at-,https://j.mp/3tBlg26
Benzinga,Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares,https://www.benzinga.com/pressreleases/21/02/g19547243/revolution-medicines-announces-closing-of-upsized-public-offering-of-common-stock-and-full-exercis,https://j.mp/3rzXLVn
